Who has invested in Chemomab?

OrbiMed, HBM Partners, Sphera are named among the investors backing Chemomab.

Chemomab Funding: $56M Raised, Series B (2025)

Chemomab funding overview

Chemomab is based in Israel. Chemomab has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2025. The round record for Chemomab runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, HBM Partners, Sphera. 3 distinct backers are named across the disclosed rounds.

Chemomab at a glance

Total raised: $56M
Latest round: Series B
Latest round date: November 2025
Headquarters: Israel
Notable investors: OrbiMed, HBM Partners, Sphera

Frequently asked about Chemomab funding

How much has Chemomab raised?: Chemomab has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Chemomab?: OrbiMed, HBM Partners, Sphera are named among the investors backing Chemomab.
What was the latest Chemomab funding round?: The most recent disclosed round is a Series B, announced in November 2025.
Where is Chemomab based?: Chemomab is based in Israel.
When did Chemomab last raise?: The last disclosed Chemomab round closed in November 2025 at Series B.

We update the Chemomab record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Israel and their backers are listed below.

Chemomab Funding: $56M Raised, Series B (2025)

Chemomab funding overview

Chemomab at a glance

Frequently asked about Chemomab funding

Companies related to Chemomab (36)

Browse related funding lists (3)